|
TSPYL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.783700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.480900E-03 |
| Normal-vs-Stage2 |
1.938580E-01 |
| Normal-vs-Stage3 |
3.90279999999965E-05 |
| Normal-vs-Stage4 |
6.27589999999678E-05 |
| Stage1-vs-Stage2 |
2.801000E-01 |
| Stage1-vs-Stage3 |
9.491600E-02 |
| Stage1-vs-Stage4 |
4.545500E-02 |
| Stage2-vs-Stage3 |
7.201900E-02 |
| Stage2-vs-Stage4 |
3.721800E-02 |
| Stage3-vs-Stage4 |
5.487600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.030800E-04 |
| Normal-vs-AfricanAmerican |
5.180200E-01 |
| Normal-vs-Asian |
1.011950E-02 |
| Caucasian-vs-AfricanAmerican |
5.777900E-02 |
| Caucasian-vs-Asian |
7.861200E-01 |
| AfricanAmerican-vs-Asian |
1.448200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.72189999994676E-06 |
| Normal-vs-Female |
3.955300E-03 |
| Male-vs-Female |
9.138900E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.278100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.739580E-03 |
| Normal-vs-Age(61-80Yrs) |
5.769100E-04 |
| Normal-vs-Age(81-100Yrs) |
4.880200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.041400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.077200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.710000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.139200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.514400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.555800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.141000E-03 |
| Classical-VS-Follicular |
7.106200E-01 |
| Classical-VS-Other |
6.395700E-02 |
| Classical-VS-Normal |
3.023500E-03 |
| Tall-VS-Follicular |
3.549800E-02 |
| Tall-VS-Other |
3.899000E-01 |
| Tall-VS-Normal |
4.10740000000853E-06 |
| Follicular-VS-Other |
1.708210E-01 |
| Follicular-VS-Normal |
1.408170E-02 |
| Other-VS-Normal |
4.403800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.476500E-03 |
| Normal-vs-N1 |
4.89380000001649E-06 |
| N0-vs-N1 |
1.216150E-02 |
|
|
